BioInvent: Good Safety Profile for BT-001

Research Note

2022-06-27

10:03

Redeye makes an adjustment to the project’s LOA based on results from BT-001’s phase I trial, part A.

RR

Richard Ramanius

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.